# MDCO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mdco

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.mdcotech.com
- Total disclosed funding: $28M
- Latest round: Series B (Sep 14, 2024)
- Investors on record: 3

## About

Based in Hangzhou, China, and founded in 2016, MDCO operates as a medical device product developer focusing on ophthalmic medical services. It has set up a R&D and production base in the U.S. The company's smart dimming materials have been patented in the United States, the European Union and China. In September 2024, MDCO raised approximately CNY 200 million in series B funding.

MDCO has new polymer material synthesis technology, ultra-precision processing technology, and high-end optical design and testing technology, and has built an artificial lens production and research technology platform. The company's main products include myopia refractive lens MPL, cataract intraocular lens IOL and myopia correction defocus lens. The products can be used in ophthalmic diseases such as cataracts, high myopia, dry eyes, etc.

The company generates revenue by developing ophthalmic medical device products for cataracts, high myopia, dry eyes and other ophthalmic diseases.

The company will use the sereis B funding to promote the registration and marketing of existing product pipelines.

## Funding rounds

- Series B, Sep 14, 2024, $28M — Decheng Capital, Sunland Capital, Hangzhou Heda Industry Fund Investment

## Investors

- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series B
- Sunland Capital — Series B
- Hangzhou Heda Industry Fund Investment — Series B